Your browser doesn't support javascript.
loading
National Knowledge-Driven Management of Obstructive Sleep Apnea-The Swedish Approach.
Grote, Ludger; Anderberg, Carl-Peter; Friberg, Danielle; Grundström, Gert; Hinz, Kerstin; Isaksson, Göran; Murto, Tarmo; Nilsson, Zarita; Spaak, Jonas; Stillberg, Göran; Söderberg, Karin; Tegelberg, Åke; Theorell-Haglöw, Jenny; Ulander, Martin; Hedner, Jan.
Afiliación
  • Grote L; Center for Sleep and Wake Disorders, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, 405 30 Gothenburg, Sweden.
  • Anderberg CP; Pulmonary Medicine, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
  • Friberg D; Kvarterskliniken, 411 36 Gothenburg, Sweden.
  • Grundström G; Department of Otorhinolaryngology, Surgical Sciences, Uppsala University, 752 36 Uppsala, Sweden.
  • Hinz K; Sleep Apnea Patient Organisation (Apne Sverige), 13332 Saltsjoebaden, Sweden.
  • Isaksson G; Department for Health Care Development, Region of Västra Götaland, 40544 Gothenburg, Sweden.
  • Murto T; Aleris Sleep Apnea Care, 11361 Stockholm, Sweden.
  • Nilsson Z; Sleep Apnea Unit, Respiratory Medicine, Umeå University Hospital, 90185 Umeå, Sweden.
  • Spaak J; Sleep Apnea Unit, ENT Department, Ystad Hospital, 271 82 Ystad, Sweden.
  • Stillberg G; Department of Cardiology and Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institute, 18288 Danderyd, Sweden.
  • Söderberg K; Sleep Apnea Unit, Capio, 70212 Örebro, Sweden.
  • Tegelberg Å; Sleep Apnea Patient Organisation (Apne Sverige), 13332 Saltsjoebaden, Sweden.
  • Theorell-Haglöw J; Sleep Apnea Patient Association (Apnefoereningen Syd), 14630 Tullinge, Sweden.
  • Ulander M; Faculty of Odontology, Malmö University, 205 06 Malmö, Sweden.
  • Hedner J; Department for Clinical Neurophysiology, 58185 Linköping, Sweden.
Diagnostics (Basel) ; 13(6)2023 Mar 20.
Article en En | MEDLINE | ID: mdl-36980487
ABSTRACT

INTRODUCTION:

This paper describes the development of "Swedish Guidelines for OSA treatment" and the underlying managed care process. The Apnea Hypopnea Index (AHI) is traditionally used as a single parameter for obstructive sleep apnea (OSA) severity classification, although poorly associated with symptomatology and outcome. We instead implement a novel matrix for shared treatment decisions based on available evidence.

METHODS:

A national expert group including medical and dental specialists, nurses, and patient representatives developed the knowledge-driven management model. A Delphi round was performed amongst experts from all Swedish regions (N = 24). Evidence reflecting treatment effects was extracted from systematic reviews, meta-analyses, and randomized clinical trials.

RESULTS:

The treatment decision in the process includes a matrix with five categories from a "very weak"" to "very strong" indication to treat, and it includes factors with potential influence on outcome, including (A) OSA-related symptoms, (B) cardiometabolic comorbidities, (C) frequency of respiratory events, and (D) age. OSA-related symptoms indicate a strong incitement to treat, whereas the absence of symptoms, age above 65 years, and no or well-controlled comorbidities indicate a weak treatment indication, irrespective of AHI.

CONCLUSIONS:

The novel treatment matrix is based on the effects of treatments rather than the actual frequency of respiratory events during sleep. A nationwide implementation of this matrix is ongoing, and the outcome is monitored in a prospective evaluation by means of the Swedish Sleep Apnea Registry (SESAR).
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Diagnostics (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Diagnostics (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Suecia
...